Immunocore and Bill & Melinda Gates Foundation collaboration
The Bill & Melinda Gates Foundation will invest up to $40 million in Immunocore to support development of Immunocore's ImmTAV and ImmTAB therapeutics for infectious diseases that pose a global health challenge